Anaplastic_Meningioma_V3__cancer_gene_panel
EGAS00001001155, EGAD00001001430Collord et al., 2018
Overview
- Modality
- Targeted panel sequencing
- Sample count
- 73
- Patient count
- 42
- Institution
- Wellcome Sanger Institute / Cambridge University Hospitals NHS Foundation Trust
- Corresponding author
- Thomas Santarius / Ultan McDermott
- Platform
- Illumina HiSeq 2000
- Access type
- controlled
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- Not reported
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- matched peripheral blood (n=19)
Priority attributes
Linked to other modalitiesPeer-reviewed
Publications
- Collord G, et al. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Scientific Reports, 2018. PMID 30202034 · DOI
Related datasets
Sources
- EGA study pagehttps://ega-archive.org/studies/EGAS00001001155
- EGA dataset pagehttps://ega-archive.org/datasets/EGAD00001001430
- PubMedhttps://pubmed.ncbi.nlm.nih.gov/30202034/
- DOIhttps://doi.org/10.1038/s41598-018-31659-0